[Experience gained with nimodipine (nemotane) in the treatment of patients with cerebral hemorrhage].
A clinical and paraclinical monitoring was conducted of the condition of those patients presenting with cerebral hemorrhage using X-ray computerized tomography, ultrasound dopplerography of extra- and intracranial arteries. Shown in the study is a positive effect of nimodipine on the risk of development of clinically significant neurological deficit with no regression undergone against the background of paraclinically recordable objective signs of constrictive-stenotic artheriopathy and formation of unfavourable (gross invalidism, vegetative state, case mortality) outcome according to the Glasgow Outcome Scale and low level of functional activity according to the Barthel Index at day 30 after the development of hemorrhage. The drug can be recommended for use in the treatment of aneurysmatic cerebral hemorrhages.
Dziak
L A
LA
Zorin
N A
NA
Golik
V A
VA
D000328:Adult; D002543:Cerebral Hemorrhage / Q000000981:diagnostic imaging / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009553:Nimodipine / Q000008:administration & dosage / Q000627:therapeutic use*; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome; D018608:Ultrasonography, Doppler; D014665:Vasodilator Agents / Q000008:administration & dosage / Q000627:therapeutic use*
D014665:Vasodilator Agents; D009553:Nimodipine